Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Literature
Wytiaz VA, et al. Doublet Therapy: Two Narrative Accounts of One Life-Changing Decision. JCO Oncology Practice 20 : 15-18, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1200/OP.23.00544
Metadata
Title
Cemiplimab
Irreversible graft rejection
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54794-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Nivolumab

Case report

Fluconazole/mineral-oil

Case report

Labetalol/Nifedipine

Case report

Cabergoline

Case report

Fluconazole

Case report

Methotrexate